1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Zikani Therapeutics, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2014

Location

Watertown MA US

Primary Industry

Pharmaceuticals

About

Founded in 2014 and based in Massachusetts, US, Zikani Therapeutics, Inc., formerly known as Macrolide Pharmaceuticals, Inc., is a preclinical-stage company that focuses on developing novel antibiotic compounds to relieve patient suffering from serious infections and rare diseases.
Current Investors
Novartis Venture Fund, SR One, Roche Venture Fund

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Biotechnology, Epidemiology, Pharmaceutical Research & Development
Website
www.zikani.com
Verticals
HealthTech, Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.